Indeed, CD44+ pancreatic ductal adenocarcinoma (PDAC) cells with an EMT phenotype display increased tumorigenicity and resistance to gemcitabine compared to CD44− cells [131]. Here, CD44 is linked to pancreatic ductal adenocarcinoma.